Skip to main content

Every night on "Mad Money," Jim Cramer offers market commentary and general investment advice, and he makes calls on specific stocks, both of his own choosing and in response to viewer requests. He relies on his many years of experience and strong track record, and he takes full responsibility for his calls.


I never shirk from admitting my mistakes; instead, I dwell on them to learn from them. I change my mind, I take losses, I own up to them

," Cramer has said.

Here we track some of his calls from the previous episode of "Mad Money" and find out, at least in the very short term, how the stocks are performing. Keep in mind that Cramer might not have been recommending that viewers take immediate action on a stock. And, of course, it's up to the individual investor to

do his or her own homework


That said, here's how some of the stocks that Cramer talked about on

Wednesday's "Mad Money" show

fared today.



: Covidien is a relatively low-risk health care stock, said Cramer, and is trading at a deep discount. He saw upside in the stock from the company's high-demand products.

On Thursday, Covidien added 80 cents, or 1.9%, to close at $42.99.


(VZ) - Get Free Report

: Cramer liked Verizon even if it's not as much of a high-flier as


(AAPL) - Get Free Report




. He said he liked Verizon's dividend.

On Thursday, Verizon closed down 22 cents, or 0.8%, at $29.16, while Apple shed 98 cents, or 0.5%, to $189.27, and Tessera closed up 72 cents, or 2.5%, at $30.05.


(AA) - Get Free Report

: In his

"Lightning Round" segment

, Cramer said that Alcoa, which just reported a profit, could "trade to the high teens." He wanted to confirm this by listening to the conference call, but he said he liked what he saw so far.

On Thursday, Alcoa gained 15 cents, or 1.1%, to close at $14.35.


( PALM): Cramer said viewers were "OK" with Palm, which he said is a "long-term winner" but also speculative. He recommended that investors in Palm diversified

On Thursday, Palm closed up 57 cents, or 3.5%, at $17.01.


(MED) - Get Free Report

: Cramer said that Medifast "fits the profil we want under Obama." He recommended waiting for the stock to come down before pulling the trigger.

On Thursday, Medifast added 91 cents, or 4.2%, to close at $22.62.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC


At the time of publication, Cramer had no positions in stocks mentioned.

Jim Cramer is a director and co-founder of He contributes daily market commentary for's sites and serves as an adviser to the company's CEO. Outside contributing columnists for and, including Cramer, may, from time to time, write about stocks in which they have a position. In such cases, appropriate disclosure is made. To see his personal portfolio and find out what trades Cramer will make before he makes them, sign up for

Action Alerts PLUS. Watch Cramer on "Mad Money" weeknights on CNBC. Click

here to order Cramer's latest book, "Mad Money: Watch TV, Get Rich," click

here to order his book, "Real Money: Sane Investing in an Insane World," click

here to get his second book, "You Got Screwed!" and click

here to order Cramer's autobiography, "Confessions of a Street Addict." While he cannot provide personalized investment advice or recommendations, he invites you to send comments on his column by

clicking here. has a revenue-sharing relationship with Traders' Library under which it receives a portion of the revenue from Traders' Library purchases by customers directed there from